Symmetric ptychotropic and nonpigmenting fixed drug eruption due to cimetidine (so-called baboon syndrome) [6]

Dermatology

Volumn 197, Issue 4, 1998, Pages 402-403

  Helmbold, P ^a   Hegemann, B ^a   Dickert, C ^a   Marsch, W Ch ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; CIMETIDINE; DIGITOXIN; DIMETHYL SULFOXIDE; DRUG METABOLITE; ECONAZOLE; MERCURY; PENTAERYTHRITYL TETRANITRATE; PENTOXIFYLLINE; PERMANGANATE POTASSIUM; PREDNISOLONE; TROXERUTIN; VERAPAMIL; ZINC OXIDE;

AGED; BUTTOCK; CASE REPORT; CONTACT DERMATITIS; DRUG ERUPTION; ERYTHEMA; HUMAN; LETTER; MALE; MICROBIOLOGICAL EXAMINATION; NOMENCLATURE; ORAL DRUG ADMINISTRATION; PARENTERAL DRUG ADMINISTRATION; PRICK TEST; PRIORITY JOURNAL; SKIN BIOPSY; SKIN PIGMENTATION; THIGH; TOPICAL DRUG ADMINISTRATION;

AGED; ANAL CANAL; ANALGESICS, NON-NARCOTIC; CIMETIDINE; DRUG ERUPTIONS; ERYTHEMA; GENITALIA, MALE; HUMANS; MALE; SKIN; SKIN TESTS;

EID: 0032424693     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018047     Document Type: Letter

References (17)

1. Andersen KE, Hjorth N, Menné T: The baboon syndrome: Systemically induced allergic contact dermatitis. Contact Dermatitis 1984;10:97-100.
2. Nakayama H, Niki F, Shono M, Hada S: Mercury exanthema: Paper read at 6th International Symposium on Contact Dermatitis, Tokyo. Contact Dermatitis 1983;9:411-417.
3. Bartolo E, Brandao FM: Mercury exanthem. Contact Dermatitis 1988;18: 172.
4. Pfeiff B, Pullmann H: Baboon-artiges Arzneimittelexanthem auf Heparin. Dtsch Dermatol 1991;39:559-560.
5. Herfs H, Schirren CG, Przybilla B, Plewig G: Das 'Baboon-Syndrom': Eine besondere Manifestation einer hämatogenen Kontaktreaktion. Hautarzt 1993;44:466-469.
6. Duve S, Worret W, Hofmann H: The baboon syndrome: A manifestation of haematogenous contact-type dermatitis. Acta Derm Venereol (Stockh) 1994;74:480-481.
7. Fernandez L, Maquiera E, Garcia-Abujeta JL, Yanez S, Rodriguez F, Martin-Gil D, Jerez J: Baboon syndrome due to mercury sensitivity. Contact Dermatitis 1995;33:56-57.
8. Lecoz CJ, Boos V, Cribier BJ, Grosshans EM, Heid E: An unusual case of mercurial baboon syndrome. Contact Dermatitis 1996;35:112.
9. Schulz ES, Diepgen TL: Klinische Characteristika und Auslöser des Baboon-Syndroms. Dermatosen 1996;44:266-269.
10. Montag G, Weber L, Gall H: Baboon-Syndrom auf Allopurinol. Akt Dermatol 1996;22:311-313.
11. Goossens C, Sass U, Song M: Baboon syndrome. Dermatology 1997;194: 421-422.
12. Merk H, Schneider R, Scholl P: Lymphocyte Stimulation by drug-modified microsomes; in Estabrook RW, Lindenlaub E, Oesch F, de Weck AL (eds): Toxicological and immunological aspects of drug metabolism and environment chemicals. Stuttgart, Schattauer, 1987; pp 211-218.
13. Hahn C, Röseler S, Fritzsche R, Schneider R, Merk HF: Allergic contact reaction to dexpanthenol: Lymphocyte stimulation test and evidence for microsomal-dependent metabolism of the allergen. Contact Dermatitis 1992;28:81-83.
14. Shiohara T: What is new in fixed drug eruption? Dermatology 1995;191: 185-187.
15. Happle R: Paraptisches Ekzem. Hautarzt 1994;45:1-3.
16. Wolf R, Brenner S, Krakowski A: Intertriginous drug eruption. Acta Derm Venereol 1992;72:441-442.
17. Shelley B, Shelley ED: Nonpigmenting fixed drug eruption as a distinctive reaction pattern: Examples caused by sensitivity to pseudoephedrine hydrochloride and tetrahydrozoline. J Am Acad Dermatol 1987;17: 403-407.